Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

FDA approves Pfizer cancer drug Inlyta

January 30, 2012
Sales and Marketing Nexavar, Pfizer, Sutent, rcc, renal cell carcinoma

Pfizer’s kidney cancer drug Inlyta has gained US approval for second line treatment for the disease. Inlyta (axitinib) is now …

News
Pfizer image

Pfizer pulls plug on Alzheimer’s drug

January 18, 2012
Research and Development, Sales and Marketing Medivation, Pfizer, dimebon

Pfizer and Medivation have written off their Alzheimer’s candidate dimebon after another Phase III failure.  The firms said a 12-month …

News

NantWorks to invest $85.5m in former Pfizer plant

January 16, 2012
Manufacturing and Production Exubera, Nantworks, Pfizer

A former Pfizer manufacturing facility in Indiana, US, looks set for a new lease of life after technology company NantWorks …

News

Pharma unprepared for annus horribilis

January 12, 2012
Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma

A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …

News

Merck facility reborn as science park

January 11, 2012
Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland

A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …

News

Crisis in the boardroom: 2011’s most dramatic departures

January 11, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, KV pharmaceuticals, Kindler, Pfizer, management

In December 2010, Jeffrey Kindler, the chief executive of Pfizer suddenly announced his departure from the company.His abrupt exit made …

Feature
Lipitor UK video

Keep prescribing Lipitor – the generics are nearly here, says Pfizer

January 5, 2012
Medical Communications, Sales and Marketing Lipitor, NHS, Pfizer, statin prescribing

Pfizer has launched a campaign to persuade UK doctors to keep prescribing Lipitor ahead of its patent expiry in May. …

News

FDA accepts Pfizer’s arthritis pill for review

December 22, 2011
Research and Development, Sales and Marketing FDA, Pfizer, tofacitinib

The FDA has accepted Pfizer’s novel arthritis pill tofacitinib for review, and could be on the US market next year. …

News
ianreadweb

Ian Read elected as chairman of the board at Pfizer

December 13, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Kindler, Pfizer

Pfizer’s chief executive and president Ian Read has been elected as the firm’s new chairman. Read succeeds George Lorch as …

Appointment
Pfizer picture

Pfizer awaits verdict on contaminated site clean-up plan

December 13, 2011
Manufacturing and Production, Sales and Marketing FDA, Pfizer, manufacturing

The US Environmental Protection Agency is due to deliver a verdict on a $205 million proposal by Pfizer to clean …

News
lamattinalee

Big pharma: big rewards come from big risks

December 5, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, R&D productivity

John LaMattina joined Pfizer in 1977 after having completed his PhD in organic chemistry, and moved up through the ranks …

Feature

Stroke crisis to hit UK unless government acts, warns report

December 5, 2011
Sales and Marketing BMS, Pfizer, Pradaxa, UK, stroke

Major improvements are needed in the treatment of atrial fibrillation to avoid a UK stroke epidemic, according to a new …

News
Teva picture

Teva gains tentative approval to sell generic Lipitor in 2012

December 5, 2011
Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

Teva has gained a tentative approval by the FDA to sell its generic form of Pfizer’s blockbuster statin Lipitor next …

News

FDA approves Ranbaxy’s generic Lipitor

December 1, 2011
Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva

The FDA will allow Ranbaxy to develop a generic version of Pfizer’s blockbuster statin Lipitor. The firm has received final …

News

Watson launches first generic Lipitor in US

November 30, 2011
Sales and Marketing Lipitor, Pfizer, Watson, atorvastin

Watson Pharmaceuticals has launched its generic version of Pfizer’s blockbuster statin Lipitor as the drug goes off patent in the …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026